Announcements Trials
Browse Landscape

Phase

Phase NA 117Phase 3 36Phase 4 29Phase 2 23Phase 1 9Phase 1/2 5Phase 2/3 4Phase EARLY_PHASE1 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 182Neoplasms 115Prostatic Neoplasms 103Multiple Myeloma 85Glioblastoma 82Pancreatic Neoplasms 75Glioma 65Brain Neoplasms 60Lung Neoplasms 58Head and Neck Neoplasms 57Melanoma 54Colorectal Neoplasms 54Carcinoma, Non-Small-Cell Lung 53Leukemia, Myeloid, Acute 51Carcinoma, Hepatocellular 50Squamous Cell Carcinoma of Head and Neck 46Recurrence 46Ovarian Neoplasms 45Lymphoma 39Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Sarcoma 35Stomach Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Neoplasm Metastasis 33Solid Tumor 31Hematologic Neoplasms 31Carcinoma, Renal Cell 30Polycystic Ovary Syndrome 27Burkitt Lymphoma 27

Interventions

Midazolam 1Lidocaine 1Electroacupuncture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Cancer Pain × Clear all
NCT07489625 2026-03-24

Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain

Qinghai Red Cross Hospital

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled

Cancer Pain

NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

National and Kapodistrian University of Athens

Phase EARLY_PHASE1 Not yet recruiting
24 enrolled

Cancer Pain, Opioid-Related Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡